Whipplewood Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Whipplewood Advisors's GILD Position: Q2 2026 in Review
Whipplewood Advisors reduced its Gilead Sciences (GILD) stake by 92% in Q2 2026, selling an estimated $34.9K and leaving 23 shares worth $2.91K. The position accounts for ﹤0.01% of the portfolio, ranked #374.
Whipplewood Advisors first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $42.7K in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Whipplewood Advisors held 23 shares of Gilead Sciences worth $2.91K as of Q2 2026.
- Whipplewood Advisors sold 265 Gilead Sciences shares in Q2 2026, an estimated $34.9K.
- Gilead Sciences made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #374 holding.
- Whipplewood Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
- Whipplewood Advisors's Gilead Sciences position peaked at $42.7K in Q2 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.